Ameritas Investment Partners, Inc. - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 74 filers reported holding OCULAR THERAPEUTIX INC in Q2 2017. The put-call ratio across all filers is 1.03 and the average weighting 0.4%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$18,039
-39.1%
5,7450.0%0.00%0.0%
Q2 2023$29,644
-2.1%
5,7450.0%0.00%0.0%
Q1 2023$30,276
+35.1%
5,7450.0%0.00%0.0%
Q4 2022$22,406
-2.6%
5,7450.0%0.00%0.0%
Q3 2022$23,0000.0%5,7450.0%0.00%0.0%
Q2 2022$23,000
-17.9%
5,7450.0%0.00%0.0%
Q1 2022$28,000
-30.0%
5,7450.0%0.00%0.0%
Q4 2021$40,000
-29.8%
5,7450.0%0.00%
-50.0%
Q3 2021$57,000
-29.6%
5,7450.0%0.00%
-33.3%
Q2 2021$81,000
-13.8%
5,7450.0%0.00%
-25.0%
Q1 2021$94,000
-21.0%
5,7450.0%0.00%
-20.0%
Q4 2020$119,000
+250.0%
5,745
+26.8%
0.01%
+150.0%
Q3 2020$34,000
-10.5%
4,5290.0%0.00%0.0%
Q2 2020$38,000
+111.1%
4,529
+24.8%
0.00%
+100.0%
Q1 2020$18,000
+125.0%
3,629
+83.4%
0.00%
Q4 2019$8,000
+33.3%
1,9790.0%0.00%
Q3 2019$6,000
-33.3%
1,9790.0%0.00%
Q2 2019$9,000
+12.5%
1,9790.0%0.00%
Q1 2019$8,0000.0%1,9790.0%0.00%
Q4 2018$8,000
-42.9%
1,9790.0%0.00%
-100.0%
Q3 2018$14,000
+7.7%
1,9790.0%0.00%0.0%
Q2 2018$13,0000.0%1,9790.0%0.00%0.0%
Q1 2018$13,000
+44.4%
1,9790.0%0.00%
Q4 2017$9,000
-25.0%
1,9790.0%0.00%
-100.0%
Q3 2017$12,000
-33.3%
1,9790.0%0.00%0.0%
Q2 2017$18,000
+100.0%
1,979
+96.7%
0.00%
Q1 2017$9,0001,0060.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q2 2017
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$19,223100.00%
Opaleye Management Inc. 6,468,000$20,309,5206.61%
DELTEC ASSET MANAGEMENT LLC 2,061,797$6,474,0431.48%
Endurant Capital Management LP 353,707$1,110,6401.00%
SECTORAL ASSET MANAGEMENT INC 969,350$3,043,7590.59%
NOTTINGHAM ADVISORS, INC. 194,266$609,9950.09%
Covestor Ltd 37,404$1170.09%
GSA CAPITAL PARTNERS LLP 233,582$7330.06%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 342,111$1,074,2290.03%
Polar Asset Management Partners Inc. 263,763$828,2160.02%
View complete list of OCULAR THERAPEUTIX INC shareholders